What is the Impact Factor of Pharmacoeconomics-Open?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Pharmacoeconomics-Open is 2.40, ranking in quartile Q2 of Web of Science (ESCI).

Is Pharmacoeconomics-Open indexed in Web of Science or Scopus?

Yes, Pharmacoeconomics-Open is indexed in Web of Science (ESCI, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.860 (Q2) and an H-index of 28.

Who publishes Pharmacoeconomics-Open and what is the Article Processing Charge (APC)?

Pharmacoeconomics-Open is published by Adis, Springer Healthcare. The estimated Article Processing Charge (APC) is approximately $3,114 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Pharmacoeconomics-Open?

The official ISO-4 abbreviation of Pharmacoeconomics-Open is "peco". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS ESCI Q2Scopus Q2SCImago #6,196Gold OA

Pharmacoeconomics-Open

Acronym:peco

•

Identifier (ISSN):2509-4262(Print)/2509-4254(Online)

•

Publisher:Adis, Springer Healthcare

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

2.4↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Pharmacoeconomics-Open

WoS Q2

Annual Impact Factor Metric

Current (2026):2.4

Scopus SJR & RankScopus Q2

0.86

#6,196

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

28 papers with at least that number of citations each

WoS: ESCIQ2

Self-Citation Rate5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

68articles/year

100% Gold OA•90% Original Research

Aims & Scope

PharmacoEconomics - Open focuses on applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. The journal includes, but is not limited to, the following research areas:Economic analysis of healthcare interventionsHealth outcomes researchCost-of-illness studiesQuality-of-life studiesAdditional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in PharmacoEconomics -Open may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Topics Covered (Recognized by AI)

Medicine93.6%Biology72.7%Internal medicine69%Economics61%Pathology59.2%Mathematics52%Political science48.3%Law47.5%Statistics47.5%Business46.2%Psychology45.1%Surgery35%Nursing31.6%Engineering30.8%Economic growth29.7%Genetics28.9%Psychiatry28.1%Health care28.1%Sociology27.9%Management27.9%Computer science27.6%Operations management24.7%Environmental health22.8%Demography22.8%Risk analysis (engineering)22.5%Chemistry21%Cost effectiveness21%Immunology20.7%

Primary Research Areas

Rank149/356

IndexESCI

Category	Index	Rank	Quartile
ECONOMICS	JCRESCI	196/626	Q2
HEALTH CARE SCIENCES & SERVICES	JCRESCI	97/194	Q2
HEALTH POLICY & SERVICES	JCRESCI	56/125	Q2
PHARMACOLOGY & PHARMACY	JCRESCI	215/356	Q3
ECONOMICS	JCIESCI	211/627	Q2
HEALTH CARE SCIENCES & SERVICES	JCIESCI	93/194	Q2
HEALTH POLICY & SERVICES	JCIESCI	68/125	Q3
PHARMACOLOGY & PHARMACY	JCIESCI	149/356	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.4

Articles / Year34

Total Citations4

2025

IF2.1

Articles / Year77

Total Citations108

2024

IF2

Articles / Year88

Total Citations408

2023

IF2

Articles / Year77

Total Citations535

2022

IF—

Articles / Year67

Total Citations695

Year	Impact Factor	Articles / Year	Total Citations
2026	2.4	34	4
2025	2.1	77	108
2024	2	88	408
2023	2	77	535
2022	—	67	695
2021	—	71	999
2020	—	55	799
2019	—	78	1,211
2018	—	44	594
2017	—	57	1,332
2016	—	7	119
2011	—	1	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,196Scopus Q2SCImago Profile

Scopus Coverage:2017-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.86

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.83

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,114 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations574

3-Year Documents218

Citable Documents213

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)2

Citations in government and international policy documents

Female Author Rate41.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Health PolicyQ2

PharmacologyQ2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ECONOMICS

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmacoeconomics-Open (acronym: peco, ISSN: 2509-4262) is a peer-reviewed international scholarly journal in the field of Multiple, published by Adis, Springer Healthcare in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.40, ranking in quartile Q2 of Web of Science (ESCI), a Scopus SJR indicator of 0.860 (Q2), an H-index of 28.

The journal enforces rigorous peer evaluation with a publication frequency of 6 issues per year, an annual output of approximately 68 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,114 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.